Utilization of a telephone interactive voice-response tobacco cessation support service in the Islamic Republic of Iran

Heydari, Gholamreza; Ahmady, Arezoo Ebn; Lando, Harry A.; Almasinia, Behroz

doi:10.26719/2014.20.5.324

Cited by 3 publications

(2 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Many studies on different aspects of quit smoking have been conducted in Iran;[ 14 15 16 17 18 19 20 ] however, none have focused on the best duration of using Champix. This study was conducted to evaluate the efficacy of Champix used for different time periods based on its cost and its effectiveness based on the duration of using.…”

Section: Introductionmentioning

confidence: 99%

Is cost of medication for quit smoking important for smokers, experience of using champix in Iranian Smoking Cessation Program 2016

Heydari

2017

Int J Prev Med

View full text Add to dashboard Cite

Background:Providing smoking cessation services are special importance to tobacco control programs. To date, Champix is a new expensive medication for smoking cessation available nationally. Champix has both agonist and antagonist activities and can reduce nicotine dependence and withdrawal symptoms. The purpose of this study was to evaluate the duration of using Champix based on its cost.Methods:This quasi-experimental study was conducted with smokers presenting to the Tanaffos Smoking Cessation Clinic in Tehran, Iran 2016. Smokers were visited by a physician 3 times at 1-week intervals for counseling. Smokers started to use Champix and stopped smoking in the 2nd week of counseling and were followed up by phone and through regular visits to the clinic at 1, 3, and 6 months postintervention. Some of them did not continue medication for 12 weeks because of its cost.Results:A total of 227 smokers including 133 males (58%) with a mean age of 43 years were enrolled of whom 116 (51.1%), 89 (43.6%), and 34 (20.6%) had quit smoking after 1, 3, and 6 months, respectively. Quit rates were significantly higher among those who used Champix for more than 6 weeks, and this rate was not correlated with age, sex, educational level, or nicotine dependence.Conclusions:Use of Champix for more than 6 weeks increases the quitting success rate compared with using for a shorter time. The cost of Champix was important for smokers and adding Champix to the list of insurance medication or getting it free of charge is needed.

show abstract

Section: Introductionmentioning

confidence: 99%

Is cost of medication for quit smoking important for smokers, experience of using champix in Iranian Smoking Cessation Program 2016

Heydari

2017

Int J Prev Med

View full text Add to dashboard Cite

show abstract

“…[ 4 ] A wide range of studies have been performed to assess the utility of telephone interactive voice-response tobacco cessation support service; and opinion of general population regarding smoking scenes in movies; hence that awareness among stakeholders regarding tobacco control can be enhanced. [ 5 6 ]…”

mentioning

confidence: 99%

World Health Organization: Do we have to intensify global tobacco control efforts?

Shrivastava¹,

Shrivastava²,

Ramasamy³

2015

J Res Med Sci

View full text Add to dashboard Cite

Telephone health services in the field of rare diseases: a qualitative interview study examining the needs of patients, relatives, and health care professionals in Germany

Babac

Frank

Pauer

et al. 2018

BMC Health Serv Res

View full text Add to dashboard Cite

BackgroundRare diseases are, by definition, very serious and chronic diseases with a high negative impact on quality of life. Approximately 350 million people worldwide live with rare diseases. The resulting high disease burden triggers health information search, but helpful, high-quality, and up-to-date information is often hard to find. Therefore, the improvement of health information provision has been integrated in many national plans for rare diseases, discussing the telephone as one access option. In this context, this study examines the need for a telephone service offering information for people affected by rare diseases, their relatives, and physicians.MethodsIn total, 107 individuals participated in a qualitative interview study conducted in Germany. Sixty-eight individuals suffering from a rare disease or related to somebody with rare diseases and 39 health care professionals took part. Individual interviews were conducted using a standardized semi-structured questionnaire. Interviews were analysed using the qualitative content analysis, triangulating patients, relatives, and health care professionals. The fulfilment of qualitative data processing standards has been controlled for.ResultsOut of 68 patients and relatives and 39 physicians, 52 and 18, respectively, advocated for the establishment of a rare diseases telephone service. Interviewees expected a helpline to include expert staffing, personal contact, good availability, low technical barriers, medical and psychosocial topics of counselling, guidance in reducing information chaos, and referrals. Health care professionals highlighted the importance of medical topics of counselling—in particular, differential diagnostics—and referrals.ConclusionsTherefore, the need for a national rare diseases helpline was confirmed in this study. Due to limited financial resources, existing offers should be adapted in a stepwise procedure in accordance with the identified attributes.

show abstract

Utilization of a telephone interactive voice-response tobacco cessation support service in the Islamic Republic of Iran

Cited by 3 publications

References 16 publications

Is cost of medication for quit smoking important for smokers, experience of using champix in Iranian Smoking Cessation Program 2016

Is cost of medication for quit smoking important for smokers, experience of using champix in Iranian Smoking Cessation Program 2016

World Health Organization: Do we have to intensify global tobacco control efforts?

Telephone health services in the field of rare diseases: a qualitative interview study examining the needs of patients, relatives, and health care professionals in Germany

Contact Info

Product

Resources

About